The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of MOR208 plus idelalisib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously treated with a Bruton's tyrosine kinase inhibitor (MIRACLE).
 
Clemens-Martin Wendtner
Honoraria - Abbvie; Gilead Sciences; Janssen; MorphoSys; Mundipharma; Roche; SERVIER
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; MorphoSys; Mundipharma; Roche; SERVIER
Research Funding - Abbvie (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; MorphoSys; Mundipharma; Roche; SERVIER
 
John C. Byrd
No Relationships to Disclose
 
Barbara Eichhorst
Consulting or Advisory Role - Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Mundipharma
Speakers' Bureau - Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Mundipharma; Roche/Genentech
Research Funding - Mundipharma; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche
 
Robin Foà
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Roche
Speakers' Bureau - Amgen; Celgene; Gilead Sciences; Janssen; Roche; Sandoz
 
Michael Hallek
No Relationships to Disclose
 
Peter Hillmen
Honoraria - Abbvie; Alexion Pharmaceuticals; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Gilead Sciences; Janssen; Roche
Research Funding - Abbvie; Gilead Sciences; Janssen; Novartis; Roche
 
Ulrich Jäger
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - Janssen; Mundipharma; Sandoz; Spectrum Pharmaceuticals; Takeda; Teva
Research Funding - Abbvie; Celgene; Eisai; Gilead Sciences; Janssen; MorphoSys; Mundipharma; Pfizer; Pharmacyclics; Roche; Sandoz; Spectrum Pharmaceuticals; Takeda
 
Peter Kelemen
Employment - MorphoSys; Sandoz
 
Kamel Laribi
Honoraria - Amgen; Novartis
Research Funding - Hospira; Janssen-Cilag; Mundipharma; Novartis; Roche; Teva
 
Talha Munir
Honoraria - Alexion Pharmaceuticals; Gilead Sciences
Consulting or Advisory Role - MorphoSys
 
Philipp B Staber
No Relationships to Disclose
 
Stephan Stilgenbauer
Honoraria - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Research Funding - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Travel, Accommodations, Expenses - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
 
Jennifer Ann Woyach
Research Funding - Acerta Pharma; Karyopharm Therapeutics; MorphoSys